<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02808234</url>
  </required_header>
  <id_info>
    <org_study_id>Nucel-2015-03</org_study_id>
    <nct_id>NCT02808234</nct_id>
  </id_info>
  <brief_title>Study of Nucel for One and Two Level Lumbar Interbody Fusion</brief_title>
  <official_title>A Single-arm, Prospective, Multi-center Study of Nucel® in Patients Receiving Interbody Fusion for One and Two Level Degenerative Disease of the Lumbar Spine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NuTech Medical, Inc</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NuTech Medical, Inc</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study is a prospective non-randomized multi-center feasibility clinical trial to
      establish the safety and efficacy of the Nucel® allograft tissue for use in lumbar interbody
      fusion procedures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Two hundred non-randomized subjects will participate in the study at up to ten clinical sites
      in the United States. Participants will be between 18 and 75 years of age. All subjects will
      have been established with lumbar spine disease at one or two levels of the lumbar spine that
      requires lumbar interbody fusion procedure as per the opinion of the treating surgeon. The
      diseases included in the study are spondylosis, degenerative disc disease and
      spondylolisthesis. All subjects who meet the inclusion criteria and do not meet the exclusion
      criteria and who elect to participate and sign the informed consent will be included in the
      study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">February 2020</completion_date>
  <primary_completion_date type="Anticipated">February 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fusion rate using non-contrast CT of the lumbar spine</measure>
    <time_frame>2 years</time_frame>
    <description>Fusion will be assessed 2 years by independent radiologist using alpha-numeric grading scale to quantify bone growth and supplemental fixation quality</description>
  </primary_outcome>
  <other_outcome>
    <measure>Neurologic Exam</measure>
    <time_frame>2 years</time_frame>
    <description>Physician conducted neurological exam</description>
  </other_outcome>
  <other_outcome>
    <measure>Visual Analogue Scale</measure>
    <time_frame>2 years</time_frame>
    <description>Patient health outcome survey</description>
  </other_outcome>
  <other_outcome>
    <measure>Oswestry Low Back Pain Disability Index</measure>
    <time_frame>2 years</time_frame>
    <description>Patient health outcome survey</description>
  </other_outcome>
  <other_outcome>
    <measure>SF-12 health survey</measure>
    <time_frame>2 years</time_frame>
    <description>Patient health outcome survey</description>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Degenerative Disc Disease</condition>
  <condition>Spondylolisthesis</condition>
  <condition>Spondylosis</condition>
  <arm_group>
    <arm_group_label>Nucel treatment group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>One or two level lumbar interbody fusion surgery with Nucel</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>One or two level lumbar interbody fusion surgery</intervention_name>
    <description>One or two level lumbar interbody fusion surgery with allograft derived from human amnion and amniotic fluid.</description>
    <arm_group_label>Nucel treatment group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Nucel</intervention_name>
    <description>Allograft derived from human amnion and amniotic fluid</description>
    <arm_group_label>Nucel treatment group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Be between 18 and 75 years of age

          2. Have clinical and/or radiological evidence of stenosis, spondylolisthesis, spondylosis
             or degenerative disc disease, or at either one or two levels of lumbar spine.

          3. In the opinion of the treating surgeon, must already be a qualified candidate for
             interbody lumbar fusion surgery with supplemental fixation.

          4. Be likely to return for regular follow-ups until the end of the study period.

          5. Be willing and able to provide Informed Consent for study participation.

        Exclusion Criteria:

          1. Previous lumbar spine fusion surgery at operative level.

          2. Back pain due to acute trauma.

          3. Clinical, laboratory and/or radiological evidence of back pain secondary to acute or
             chronic infection, malignancy, other space occupying lesions and metabolic bone
             demineralization diseases (e.g. osteomalacia, gout, Paget's disease etc.)

          4. No chronic steroid or chronic prescription NSAID use within three (3) months prior to
             surgery.

          5. Any active malignancy, infectious process, or documented chronic autoimmune disease.

          6. Any other concurrent medical disease or treatment that might impair normal healing
             process.

          7. Recent history (within past 6 months) of any chemical or alcohol dependence.

          8. Morbid obesity (BMI &gt; 40).

          9. Currently a prisoner.

         10. Currently experiencing a major mental illness (psychosis, schizophrenia, major
             affective disorder) which may indicate that the symptoms are psychological rather than
             of physical origin.

         11. Pregnancy at the time of enrollment or planned pregnancy, which would interfere with
             follow-up imaging.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pierce Nunley, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Spine Institute of Louisiana</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kelly Frank, MS</last_name>
    <phone>512-751-7747</phone>
    <email>kfrank@louisianaspine.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marcus Stone, PhD</last_name>
    <phone>318-629-5585</phone>
    <email>mstone@louisianaspine.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Florida Orthopaedic Insitute</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33609</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Debbi Warren, RN, CCRC</last_name>
      <phone>813-978-9700</phone>
      <phone_ext>6766</phone_ext>
      <email>dwarren@foreonline.org</email>
    </contact>
    <investigator>
      <last_name>Steven Tresser, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spine Institute of Louisiana</name>
      <address>
        <city>Shreveport</city>
        <state>Louisiana</state>
        <zip>71101</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kelly Frank, MS</last_name>
      <phone>512-751-7747</phone>
      <email>kfrank@louisianaspine.org</email>
    </contact>
    <contact_backup>
      <last_name>Marcus Stone, PhD</last_name>
      <phone>318-629-5585</phone>
      <email>mstone@louisianaspine.org</email>
    </contact_backup>
    <investigator>
      <last_name>Pierce Nunley, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Carolina Neurosurgery &amp; Spine</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28204</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peggy Boltes</last_name>
      <phone>704-376-1605</phone>
      <email>Peggy.Boltes@CNSA.com</email>
    </contact>
    <investigator>
      <last_name>Dr. Dom Coric, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 7, 2016</study_first_submitted>
  <study_first_submitted_qc>June 16, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 21, 2016</study_first_posted>
  <last_update_submitted>April 2, 2018</last_update_submitted>
  <last_update_submitted_qc>April 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
    <mesh_term>Spondylolisthesis</mesh_term>
    <mesh_term>Spondylosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

